- Home
- CCS vs OCUL Comparison
CCS vs OCUL Comparison
Compare CCS & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCS | OCUL |
|---|---|---|
| Founded | 2000 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CCS | OCUL |
|---|---|---|
| Price | $61.64 | $10.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 11 |
| Target Price | ★ $70.50 | $22.90 |
| AVG Volume (30 Days) | 235.7K | ★ 7.8M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 1.84% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.86 | N/A |
| Revenue | ★ $4,117,816,000.00 | $1,990,000.00 |
| Revenue This Year | N/A | $9.35 |
| Revenue Next Year | $10.84 | $92.88 |
| P/E Ratio | $13.00 | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $50.42 | $6.23 |
| 52 Week High | $76.00 | $16.44 |
Technical Indicators
Market Signals| Indicator | CCS | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 31.57 | 54.34 |
| Support Level | $61.12 | $6.55 |
| Resistance Level | $62.84 | $12.63 |
| Average True Range (ATR) | 2.19 | 0.79 |
| MACD | -1.19 | 0.34 |
| Stochastic Oscillator | 6.42 | 76.00 |
Price Performance
Historical ComparisonAbout CCS Century Communities Inc.
Century Communities Inc is engaged in the development, design, construction, marketing, and selling of single-family attached and detached homes. It has five homebuilding segments: West, Mountain, Texas, Southeast, and Century Complete. Its sixth reportable segment is financial services operations, which provides mortgage, title, and insurance services to homebuyers. It has acquired land for homebuilding operations with the primary intent to develop and construct single-family detached or attached homes for sale on the acquired land. The company sells homes through its sales representatives and independent real estate brokers. The company generates the majority of its revenue from the Mountain segment.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.